BLACAT1 and central nervous system cancer: Lnc015192 regulates miR-34a and subsequently targets Adam12 in breast cancer through a ceRNA mechanism [23], and studies have also shown that LncRNA BLACAT1 promotes glioma development by binding to miR-605-3p to regulate VASP expression and promote glioma development and progression [24].